Recruiting nowPhase 1, Phase 2
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
Updated 2026-09-01 · NCT05972564See eligibility →
Sponsor
Clinical trials sponsored by Vanderbilt University Medical Center
Active studies whose public registry record names Vanderbilt University Medical Center as lead sponsor.
17active studies
7recruiting now
1countries represented
2largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 2
GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
Updated 2026-05-26 · NCT07221214See eligibility →
Recruiting nowPhase 1, Phase 2
Sympathetic Mechanisms in Obesity-Crossover Design
Updated 2026-02-27 · NCT05312892See eligibility →
Recruiting nowEarly Phase 1
GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
Updated 2025-12-18 · NCT06338553See eligibility →
Recruiting nowNot applicable
The ADAPT Trial: Adapting Evidence-Based Obesity Interventions in Community Settings
Updated 2025-12-11 · NCT06546696See eligibility →
Recruiting nowNot applicable
Gut Microbiota in Metabolic Surgery
Updated 2025-11-04 · NCT05000996See eligibility →
Recruiting nowNot applicable
The Dose Trial: Dose Intensity of Behavioral Interventions for Childhood Obesity
Updated 2025-09-08 · NCT06654323See eligibility →
Opening soonPhase 2
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide
Updated 2026-08-28 · NCT07760948See eligibility →
Opening soonNot applicable
Transition to Ambulatory Bariatric Surgery (TABS) Trial
Updated 2026-08-18 · NCT07011628See eligibility →
Opening soonNot applicable
Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Updated 2026-08-12 · NCT07760909See eligibility →
Updated 2026-06-11 · NCT07642635See eligibility →
Invitation onlyNot applicable
Physiologic and Functional Adaptations of Insulin Sensitive Tissues
Updated 2025-12-18 · NCT03407833See eligibility →
Active, not recruitingPhase 2, Phase 3
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Updated 2026-08-04 · NCT06162715See eligibility →
Active, not recruitingNot applicable
Comparison of Body Composition Changes With Weight Loss Interventions
Updated 2026-07-14 · NCT07115069See eligibility →
Active, not recruitingPhase 2
Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)
Updated 2026-06-24 · NCT05254314See eligibility →
Active, not recruitingPhase 1
Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity
Updated 2026-03-02 · NCT03318094See eligibility →
Active, not recruitingNot applicable
Competency Based Approaches for Community Health 2
Updated 2025-12-02 · NCT04971044See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.